Clinical evaluation of serum antimitochondrial antibody-negative primary biliary cirrhosis

Hepatobiliary and Pancreatic Diseases International

Volumn 3, Issue 2, 2004, Pages 288-291

  Zhang, Fu Kui ^a   Jia, Ji Dong ^a   Wang, Bao En ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Antimitochondrial antibody; Primary biliary cirrhosis

Indexed keywords

ANTINUCLEAR ANTIBODY; IMMUNOGLOBULIN M; MITOCHONDRION ANTIBODY; SMOOTH MUSCLE ANTIBODY;

ADULT; AGE DISTRIBUTION; ANTIBODY BLOOD LEVEL; BIOCHEMISTRY; CLINICAL EXAMINATION; CLINICAL FEATURE; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOLOGY; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIMARY BILIARY CIRRHOSIS; REVIEW; SENSITIVITY AND SPECIFICITY; SEROLOGY; SEX DIFFERENCE;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; FEMALE; HUMANS; LIVER CIRRHOSIS, BILIARY; MALE; MIDDLE AGED; MITOCHONDRIA;

EID: 2442717714     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (30)

1. Heathcote EJ. Management of primary biliary cirrhosis. The American association for the study of liver diseases practice guidelines. Hepatology 2000;31:1005-1013.
2. Lacerda MA, Ludwig J, Dickson ER, Jorgensen R-A, Lindor KD. Antimitochondrial antibody-negative primary biliary cirrhosis. Am J Gastroenterol 1995;90:247-249.
3. James OF, Bhopal BL, Howel D, Gray J, Burt AD, Metcalf JV. Primary biliary cirrhosis once rare, now common in the United Kingdom? Hepatology 1999;30:390-394.
4. Prince MI, James OF. The epidemiology of primary biliary cirrhosis. Clin Liver Dis 2003;7:795-819.
5. Zhang FK, Jia JD, Cui RT, Wang B, Wang H. Clinical features of forty patients with primary biliary cirrhosis. Chin Med J 2002;115:904-908.
6. Kinoshita H, Omagari K, Whittingham S, Kato Y, Ishibashi H, Sugi K, et al. Autoimmune cholangitis and primary biliary cirrhosis--an autoinunune enigma. Liver 1999;19:122-128.
7. Kim WR, Poterucha JJ, Jorgensen RA, Batts KP, Homburger HA, Dickson ER, et al. Does antimitochondrial antibody status affect response to treatment in patients with primary biliary cirrhosis? Outcomes of ursodeoxycholic acid therapy and liver transplantation. Hepatology 1997;26-22-26.
8. Invernizzi P, Crosignam A, Battezzati PM, Covini G, de Valle G, Larghi A, et al. Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and-negative primary biliary cirrhosis. Hepatology 1997;25:1090-1095.
9. Goodman ZD, McNally PR, Davis DR, Ishak KG. Autoimmune cholangitis: a variant of primary biliary cirrhosis. Clinicopathologic and serologic correlations in 200 cases. Dig Dis Sci 1995;40:1232-1242.
10. Taylor SL, Dean PJ, Riely CA. Primary autoinumme cholangitis. An alternative to antimitochondrial antibody-negative primary biliary cirrhosis. Am J Surg Pathol 1994;18:91-99,
11. Michieletti P, Wanless IR, Katz A, Scheuer PJ, Yeaman SJ, Bassendine MF, et al. Antumtochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis. Gut 1994;35:260-265.
12. Watanabe S, Deguchi A, Uchida N, Kurokohchi K, Arima K, Nishioka M, et al. Histopathologic comparison of anti-mitochondrial antibody-positive primary biliary cirrhosis and autoimmune cholangiopathy. Hepatol Res 2001;19:41-51.
13. Neuberger J, Thomson R. PBC and AMA-what is the connection? Hepatology 1999;29:271-276.
14. Gordon SC, Quattrociocchi-Longe TM, Khan BA, Kodali VP, Chen J, Silverman AL, et al. Antibodies to carbonic anhydrase in patients with immune cholangiopathies. Gastroenterology 1995;108:1802-1809.
15. Akisawa N, Nishimori I, Miyaji E, Iwasaki S, Maeda T, Shimizu H, et al. The ability of anti-carbonic anhydrase II antibody to distinguish autoimmune cholangitis from primary biliary cirrhosis in Japanese patients. J Gastroenterol 1999; 34: 366-371.
16. Comay D, Cauch-Dudek K, Hemphill D, Diamandis E, Wariless I, Heathcote EJ. Are antibodies to carbonic anhydrase II specific for anti-mitochondrial antibody-negative primary biliary cirrhosis? Dig Dis Sci 2000;45:2018-2021.
17. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Autoimmune cholangitis within the spectrum of autoimmune liver disease. Hepatology 2000;31:1231-1238.
18. Stone J, Wade JA, Cauch-Dudek K, Ng C, Lindor KD, Heathcote EJ. Human leukocyte antigen Class II associations in serum antimitochondrial antibodies (AMA) -positive and AMA-negative primary biliary cirrhosis. J Hepatol 2002;36:8-13.
19. Tsuneyama K, van De Water J, van Thiel D, Coppel R, Ruebner B, Nakanuma Y, et al. Abnormal expression of PDC-E2 on the apical surface of biliary epithelial cells in patients with antimitochonrial antibody-negative primary biliary cirrhosis. Hepatology 1995;22:1440-1446.
20. Neuberger J. Antibodies and primary biliary cirrhosis-piecing together the jigsaw. J Hepatol 2002;36:126-129.
21. Gisbert JP, Jones EA, Pagares JM, Moreno-Otero R. Review article: is there an optimal therapeutic regimen for antimitochondrial antibody-negative primary biliary cirrhosis (autoimmune cholangitis) ? Aliment Pharmacol Ther 2003;17:17-27.
22. Masuda J, Omagari K, Matsuo I, Kinoshita H, Sakimura K, Hazama H, et al. Changes in titers of antimitochondrial and antinuclear antibodies during the course of primary biliary cirrhosis. J Gastroenterol Hepatol 2001;16:239-243.
23. Cho YJ, Han DS, Kim TY, Jang SJ, Jeon YC, Sohn JH, et al. Negative conversion of antimitochondrial antibody in primary biliary cirrhosis: a case of autoimmune cholangitis. J Korean Med Sci 1999;14:102-106.
24. Kitami N, Komada T, Ishii H, Shimizu H, Adachi H, Yamaguchi Y, et al. Immunological study of anti-M2 in antimitochondrial antibody-negative primary biliary cirrhosis. Intern Med 1995;34:496-501.
25. Nakajima M, Shimizu H, Miyazaki A, Watanabe S, Kitami N, Sato N. Detection of IgA, IgM, and IgG subclasses of anti-M2 antibody by immunoblotting in autoimmune cholangitis: is autoimmune cholangitis an early stage of primary biliary cirrhosis? J Gastroenterol 1999;34:607-612.
26. Miyakawa H, Tanaka A, Kikuchi K, Matsushita M, Kitazawa E, Kawaguchi N, et al. Detection of antimitochondrial antoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens. Hepatology 2001;34:243-248.
27. Muratori P, Muratori L, Gershwin ME, Czaja AJ, Pappas G, MacCariello S, et al. True antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both? Clin Exp Immunol 2004;135:154-158.
28. Jiang XH, Fang XY, Zhong RQ, Wang XP, Hu Y, Kong XT. Development of an enzyme immune assay for detecting M2 autoantibodies specific for primary biliary cirrhosis. Hepatobiliary Pancreat Dis Int 2003;2:290-294.
29. Kadokawa Y, Omagari K, Hazama H, Ohba K, Masuda J, Kinoshita H, et al. Evaluation of newly developed ELISA using "MESACUP-2 test mitochondrial M2" kit for the diagnosis of primary biliary cirrhosis. Clin Biochem 2003;36:203-210.
30. Miyakawa H, Kitazawa E, Fujikawa H, Kikuchi K, Abe K, Kawaguchi N, et al. Analysis of two major anti-M2 antibodies (anti-PDC-E2/anti-BCOADC-E2) in primary biliary cirrhosis: relationship to titers of immunofluorescent, anti-mitochondrial antibody. Hepatol Res 2000;18:1-9.